Complementary and Alternative Medicine for Atopic Dermatitis: An Evidence-Based Review

American Journal of Clinical Dermatology

Volumn 17, Issue 6, 2016, Pages 557-581

  Vieira, Brittany L ^a   Lim, Neil R ^a   Lohman, Mary E ^a   Lio, Peter A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Medical Dermatology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FATTY ACID; HERBACEOUS AGENT; MINERAL; PRIMROSE OIL; VITAMIN; VITAMIN D; TRACE ELEMENT;

ACUPRESSURE; ACUPUNCTURE; ALTERNATIVE MEDICINE; ATOPIC DERMATITIS; BALNEOTHERAPY; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; HUMAN; HYPNOSIS; MASSAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; TOPICAL TREATMENT; TREATMENT FAILURE; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; DERMATITIS, ATOPIC; ORAL DRUG ADMINISTRATION; PROCEDURES; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; BALNEOLOGY; COMPLEMENTARY THERAPIES; DERMATITIS, ATOPIC; HUMANS; MICRONUTRIENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84995768055     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.1007/s40257-016-0209-1     Document Type: Review

References (97)

1. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Investig Dermatol. 2011;131(1):67–73.
2. Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol. 1990;70(5):421–4.
3. Simpson EL, Basco M, Hanifin J. A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat. 2003;14(3):144–7.
4. Aguiar Júnior N dos R, Costa IMC. The use of alternative or complementary medicine for children with atopic dermatitis. An Bras Dermatol. 2011;86(1):167–8.
5. Strom MA, Lio PA. Alternative medicine in pediatric dermatology: what is the evidence? Curr Derm Rep. 2014. doi:10.1007/s13671-014-0086-x.
6. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
7. Silverberg JI. Atopic dermatitis: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):149–64.
8. Che-Yi C, Wen CY, Min-Tsung K, Chiu-Ching H. Acupuncture in haemodialysis patients at the Quchi (LI11) acupoint for refractory uraemic pruritus. Nephrol Dial Transplant. 2005;20(9):1912–5.
9. Pfab F, Huss-Marp J, Gatti A, et al. Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema—a blinded, randomized, placebo-controlled, crossover trial. Allergy. 2010;65(7):903–10.
10. Pfab F, Kirchner MT, Huss-Marp J, et al. Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial. Allergy. 2012;67(4):566–73.
11. Lee KC, Keyes A, Hensley JR, et al. Effectiveness of acupressure on pruritus and lichenification associated with atopic dermatitis: a pilot trial. Acupunct Med. 2012;30(1):8–11.
12. Shenefelt PD. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther. 2003;16:114–22.
13. Sokel B, Kent CA, Lansdown R, et al. A comparison of hypnotherapy and biofeedback in the treatment of childhood atopic eczema. Contemp Hypnosis. 1993;10(3):145–54.
14. Miller RM, Coger RW. Skin conductance conditioning with dyshidrotic eczema patients. Br J Dermatol. 1979;101(4):435–40.
15. Schut C. Psychophysiological effects of stress management in patients with atopic dermatitis: a randomized controlled trial. Acta Derm Venereol. 2013;93(1):57–61.
16. Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol. 1995;63(4):624–35.
17. Schachner L, Field T, Hernandez-Reif M, Duarte AM, Krasnegor J. Atopic dermatitis symptoms decreased in children following massage therapy. Pediatric dermatology. 1998;15(5):390–95.
18. Bae BG, Oh SH, Park CO, et al. Progressive muscle relaxation therapy for atopic dermatitis: objective assessment of efficacy. Acta Derm Venereol. 2012;92(1):57–61.
19. Anderson C, Lis-Balchin M, Kirk-Smith M. Evaluation of massage with essential oils on childhood atopic eczema. Phytother Res PTR. 2000;14(6):452–6.
20. Fishbein AB, Vitaterna O, Haugh IM, et al. Nocturnal eczema: review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. J Allergy Clin Immunol. 2015;136(5):1170–7.
21. Matz H, Orion E, Wolf R. Balneotherapy in dermatology. Dermatol Ther. 2003;16:132–40.
22. McNally NJ, Williams HC, Phillips DR, et al. Atopic eczema and domestic water hardness. Lancet. 1998;352(9127):527–31.
23. Thomas KS, Koller K, Dean T, et al. A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET). Health Technol Assess (Winchester, England). 2011;15(8):v–vi, 1–156.
24. Togawa Y. Ultrapure soft water improves the skin barrier function of child atopic dermatitis: the first report. J Investig Dermatol. 2012;132:S68.
25. Heinlin J, Schiffner-Rohe J, Schiffner R, et al. A first prospective randomized controlled trial on the efficacy and safety of synchronous balneophototherapy vs. narrow-band UVB monotherapy for atopic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2011;25(7):765–73.
26. Farina S, Gisondi P, Zanoni M, et al. Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy. J Dermatol Treat. 2011;22(6):366–71.
27. Zhang GG, Lee W, Bausell B, et al. Variability in the traditional Chinese medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritis. J Altern Complement Med. 2005;11(3):415–21.
28. Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evid Based Complement Alternat Med. 2015;2015:316706.
29. Tan HY, Zhang AL, Chen D, et al. Chinese herbal medicine for atopic dermatitis: a systematic review. J Am Acad Dermatol. 2013;69(2):295–304. doi:10.1016/j.jaad.2013.01.019.
30. Cheng HM, Chiang LC, Jan YM, et al. The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol. 2011;155(2):141–8.
31. Choi IH, Kim S, Kim Y, Yun Y. The effect of TJ-15 plus TJ-17 on atopic dermatitis: a pilot study based on the principle of pattern identification. J Altern Complemen Med (New York, N.Y.). 2012;18(6):576–82.
32. Xq X, Cheng S, Ma H, et al. Combination of flying needle with Chinese herbal medicine in the treatment of atopic dermatitis: a clinical trial. Pak J Pharm Sci. 2014;27(5 Suppl):1687–90.
33. Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol. 1992;126:179–84.
34. Sheehan MP, Rustin MH, Atherton DJ, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet. 1992;340(8810):13–7.
35. Fung AY, Look PC, Chong LY, et al. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol. 1999;38(5):387–92.
36. Henderson CA, Morris A, Wilson A, Ilchyshyn A. An open study comparing the efficacy of two different Chinese herbal therapy formulations in atopic eczema and their effects on circulating activated T-lymphocytes. J Dermatol Treat. 2000;11(2):91–96.
37. Kobayashi H, Ishii M, Takeuchi S, et al. Efficacy and safety of a traditional herbal medicine, hochu-ekki-to in the long-term management of Kikyo (Delicate Constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study. Evid Based Complement Altern Med. 2010;7(3):367–73.
38. Hon KL, Leung TF, Ng PC, et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double-blind, placebo-controlled study. Hong Kong Med J = Xianggang yi xue za zhi/Hong Kong Academy of Medicine. 2011;17(Suppl 2):38–40.
39. Shapira MY, Raphaelovich Y, Gilad L, et al. Treatment of atopic dermatitis with herbal combination of Eleutherococcus, Achillea millefolium, and Lamium album has no advantage over placebo: a double blind, placebo-controlled, randomized trial. J Am Acad Dermatol. 2005;52:691–3.
40. Winkelmann RR, Del Rosso J, Rigel DS. Polypodium leucotomos extract: a status report on clinical efficacy and safety. J Drugs Dermatol. 2015;14(3):254–61.
41. Ramirez-Bosca A, Zapater P, Betlloch I, et al. Polypodium leucotomos extract in atopic dermatitis: a randomized, double-blind, placebo-controlled, multicenter trial. Actas Dermosifiliogr. 2012;103(7):599–607.
42. Schempp CM, Windeck T, Hezel S, Simon JC. Topical treatment of atopic dermatitis with St. John’s wort cream–a randomized, placebo controlled, double blind half-side comparison. Phytomedicine. 2003;10(Suppl 4):31–7.
43. Patzelt-Wenczler R, Ponce-Poschl E. Proof of efficacy of Kamillosan(R) cream in atopic eczema. Eur J Med Res. 2000;5(4):171–5.
44. Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatol Treat. 2003;14(3):153–7.
45. Klovekorn W, Tepe A, Danesch U. A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis. Int J Clin Pharmacol Ther. 2007;45(11):583–91.
46. Eichenfield LF, McCollum A, Msika P. The benefits of sunflower oleodistillate (SOD) in pediatric dermatology. Pediatr Dermatol. 2009;26(6):669–75.
47. De Belilovsky C, Roo-Rodriguez E, Baudouin C, et al. Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis. J Dermatol Treat. 2011;22(6):359–65.
48. Danby SG, AlEnezi T, Sultan A, et al. Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care. Pediatr Dermatol. 2013;30(1):42–50.
49. Cork MJ, Danby SG, Vasilopoulos Y et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892–1908.
50. Lio PA, Lee M, LeBovidge J, et al. Clinical management of atopic dermatitis: practical highlights and updates from the atopic dermatitis practice parameter 2012. J Allergy Clin Immunol Pract. 2014;2(4):361–9.
51. Nakamura Y, Oscherwitz J, Cease KB, et al. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503(7476):397–401.
52. Verallo-Rowell VM, Dillague KM, Syah-Tjundawan BS. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermatitis. 2008;19(6):308–15.
53. Evangelista MT, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol. 2014;53(1):100–8.
54. Lee J, Bielory L. Complementary and alternative interventions in atopic dermatitis. Immunol Allergy Clin N Am. 2010;30(3):411–24.
55. Anstey A, Quigley M, Wilkinson JD. Topical evening primrose oil as treatment for atopic eczema. J Dermatol Treat. 1990;1(4):199–201.
56. Ferreira MJ, Fiadeiro T, Silva M, Soares AP. Topical-linolenic acid therapy in atopic dermatitis. A clinical and biometric evaluation. Allergo J. 1998;7(4):213–16.
57. Kanehara S, Ohtani T, Uede K, Furukawa F. Clinical effects of undershirts coated with borage oil on children with atopic dermatitis: a double-blind, placebo-controlled clinical trial. J Dermatol. 2007;34(12):811–5.
58. Korting HC, Schollmann C, Cholcha W, Wolff L. Efficacy and tolerability of pale sulfonated shale oil cream 4 % in the treatment of mild to moderate atopic eczema in children: a multicentre, randomized vehicle-controlled trial. J Eur Acad Dermatol Venereol. 2010;24(10):1176–82.
59. Brown WR, Hansen AE. Arachidonic and linoleic acid of the serum in normal and eczematous human subjects. Proc Soc Exp Biol Med. 1937;36:113–7.
60. Bamford JT, Ray S, Musekiwa A, et al. Oral evening primrose oil and borage oil for eczema. Cochrane Database Syst Rev. 2013;4:CD004416.
61. Henz BM, Jablonska S, van de Kerkhof PC, et al. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol. 1999;140(4):685–8.
62. Takwale A, Tan E, Agarwal S, et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ (Clinical research ed.). 2003;327(7428):1385.
63. Valsecchi R, Di Landro A, Pansera B, Reseghetti A. Gammalinolenic acid in the treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 1996;7(1):77–9.
64. Bordoni A, Biagi PL, Masi M, et al. Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs Exp Clin Res. 1988;14(4):291–7.
65. Schalin-Karrila M, Mattila L, Jansen CT, et al. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. Br J Dermatol. 1987;117 (1):11–19.
66. Humphreys F, Symons JA, Brown HK, et al. The effects of gamolenic acid on adult atopic eczema and premenstrual exacerbation of eczema. Eur J Dermatol. 1994;4 (8):598–603.
67. Senapati S, Banerjee S, Gangopadhyay DN. Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial. Indian J Dermatol Venereol Leprol. 2008;74(5):447–52.
68. Bamford JT, Gibson RW, Renier CM. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). J Am Acad Dermatol. 1985;13(6):959–65.
69. Williams HC. Evening primrose oil for atopic dermatitis. BMJ. 2003;327(7428):1258–9.
70. Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet. 1993;341(8860):1557–60.
71. Biagi PL, Bordoni A, Hrelia S, et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res. 1994;20(2):77–84.
72. Chung B. Dose-dependent effects of evening primrose oil in children and adolescents with atopic dermatitis. Ann Dermatol. 2013;25(3):285–91.
73. Wright S, Burton JL. Oral evening-primrose-seed oil improves atopic eczema. Lancet. 1982;2(8308):1120–2.
74. Mayser P, Mayer K, Mahloudjian M, et al. A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. JPEN J Parenter Enteral Nutr. 2002;26(3):151–8.
75. Bjorneboe A, Soyland E, Bjorneboe GE, Rajka G, Drevon CA. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol. 1987;117(4):463–9.
76. Soyland E, Funk J, Rajka G, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol. 1994;130(6):757–64.
77. Callaway J, Schwab U, Harvima I, et al. Efficacy of dietary hempseed oil in patients with atopic dermatitis. J Dermatol Treat. 2005;16(2):87–94.
78. Koch C, Dolle S, Metzger M, et al. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. Br J Dermatol. 2008;158(4):786–92.
79. Gimenez-Arnau A, Barranco C, Alberola M, et al. Effects of linoleic acid supplements on atopic dermatitis. Adv Exp Med Biol. 1997;433:285–9.
80. Bath-Hextall FJ, Jenkinson C, Humphreys R, Williams HC. Dietary supplements for established atopic eczema. Cochrane Database Syst Rev. 2012;2:CD005205.
81. Mabin DC, Hollis S, Lockwood J, David TJ. Pyridoxine in atopic dermatitis. Br J Dermatol. 1995;133(5):764–7.
82. Fairris GM, Perkins PJ, Lloyd B, Hinks L, Clayton BE. The effect on atopic dermatitis of supplementation with selenium and vitamin E. Acta Derm Venereol. 1989;69(4):359–62.
83. Ewing CI, Gibbs AC, Ashcroft C, David TJ. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr. 1991;45(10):507–10.
84. Mohan GC, Lio PA. Comparison of dermatology and allergy guidelines for atopic dermatitis management. JAMA Dermatol. 2015. doi:10.1001/jamadermatol.2015.0250.
85. Amestejani M, Salehi BS, Vasigh M, et al. Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol JDD. 2012;11(3):327–30.
86. Camargo CA Jr, Ganmaa D, Sidbury R, et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol. 2014;134(4):831–835.e831.
87. Hata TR, Audish D, Kotol P, et al. A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2014;28(6):781–9.
88. Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008;159(1):245–7.
89. Javanbakht MH, Keshavarz SA, Djalali M, et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatol Treat. 2011;22(3):144–50.
90. Faghihi G, Iraji F, Shahingohar A, Saidat A. The efficacy of ‘0.05 % clobetasol + 2.5 % zinc sulphate’ cream vs. ‘0.05 % clobetasol alone’ cream in the treatment of the chronic hand eczema: a double-blind study. J Eur Acad Dermatol Venereol JEADV. 2008;22(5):531–6.
91. Januchowski R. Evaluation of topical vitamin B(12) for the treatment of childhood eczema. J Altern Complement Med (New York, N.Y.). 2009;15(4):387–89.
92. Stucker M, Pieck C, Stoerb C, et al. Topical vitamin B12–a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial. Br J Dermatol. 2004;150(5):977–83.
93. D’Aurizio F, Villalta D, Metus P, et al. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid disease? Autoimmun Rev. 2015;14(5):363–9.
94. Schoni MH, Nikolaizik WH, Schoni-Affolter F. Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol. 1997;112(3):238–46.
95. Tripodi S, Di Rienzo Businco A, Panetta V, et al. Lack of efficacy of topical furfuryl palmitate in pediatric atopic dermatitis: a randomized double-blind study. J Investig Allergol Clin Immunol. 2009;19(3):204–209.
96. Kwon H. Combination of glucosamine improved therapeutic effect of low-dose cyclosporin A in patients with atopic dermatitis: a pilot study. J Dermatol. 2013;40(3):207–10.
97. Vita D, Passalacqua G, Di Pasquale G, et al. Ass’s milk in children with atopic dermatitis and cow’s milk allergy: crossover comparison with goat’s milk. Pediatr Allergy Immunol. 2007;18(7):594–8.